On Aug. 3, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Ben Perkins
Ben Perkins, Assistant Editor, is a reporter with International Trade Today and its sister publications, Trade Law Daily and Export Compliance Daily, where he covers sanctions, court rulings, and other international trade issues. He previously worked as a trade analyst for a Washington D.C. advisory firm. Ben holds a B.A. in English from the University of New Hampshire and an M.A. in International Relations from American University. Ben joined the staff of Warren Communications News in 2022.
The Commerce Department and the International Trade Commission published the following Federal Register notices Aug. 3 on AD/CVD proceedings:
The International Trade Commission published notices in the Aug. 3 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
On Aug. 2, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Importers should be careful when combining several goods into a single shipment, which can save them money in fees but also present some complications, Flexport executives said during an Aug. 2 webinar hosted by the company.
The International Trade Commission published notices in the Aug. 2 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department and the International Trade Commission published the following Federal Register notices Aug. 2 on AD/CVD proceedings:
On Aug. 1, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notice on Aug. 2:
The International Trade Commission published notices in the Aug. 1 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):